Prof. Dr. Markus Diefenbacher
LMU Professor of Immuno-Oncology of the Lung and Pleura
Head of Helmholtz Research Group “Experimental Oncology”

Dr. Rüdiger Jankowsky
CEO AATec Medical

Topic: New therapeutics for inflammatory respiratory diseases
Inflammatory airway diseases represent a major global health challenge. Hundreds of millions of patients suffer from COPD, asthma, bronchiectasis, pulmonary fibrosis, and other conditions of the lungs. While treatment options remain limited, recent years have seen significant advances in new approaches. Dr. Rüdiger Jankowsky, CEO of AATec, will provide an overview of emerging treatment modalities and explain how AATec develops new biotherapeutics for the rapidly growing area of inflammatory lung diseases.

Anne Burger
CFO CatalYm

Dominik Schumacher
CEO Tubulis